Targeting Mast Cells with Biologics

Mast cells are tissue-resident allergic effector cells that cause many symptoms associated with IgE –mediated immediate hypersensitivity reactions. Beginning with allergen-specific therapy over a century ago, biologics have been used to target mast cells in patients in order to reduce allergic symptoms and reactions. This review discusses the history and current outlook of the use of biologics i n mast cell–associated diseases and reactions.
Source: Immunology and Allergy Clinics of North America - Category: Allergy & Immunology Authors: Source Type: research